Prudential Financial Inc. Increases Stock Position in Embecta Corp. (NASDAQ:EMBC)

Prudential Financial Inc. grew its stake in Embecta Corp. (NASDAQ:EMBC) by 41.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 154,580 shares of the company’s stock after buying an additional 45,290 shares during the period. Prudential Financial Inc. owned approximately 0.27% of Embecta worth $3,192,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Intech Investment Management LLC purchased a new position in Embecta in the third quarter worth $211,000. Rockefeller Capital Management L.P. boosted its holdings in shares of Embecta by 3.7% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 90,072 shares of the company’s stock worth $1,270,000 after purchasing an additional 3,231 shares in the last quarter. Verition Fund Management LLC boosted its holdings in shares of Embecta by 45.3% in the 3rd quarter. Verition Fund Management LLC now owns 17,682 shares of the company’s stock worth $249,000 after purchasing an additional 5,511 shares in the last quarter. Quarry LP bought a new position in shares of Embecta during the 3rd quarter valued at about $30,000. Finally, Jane Street Group LLC raised its holdings in shares of Embecta by 156.1% during the 3rd quarter. Jane Street Group LLC now owns 176,487 shares of the company’s stock valued at $2,488,000 after buying an additional 107,567 shares in the last quarter. Institutional investors own 93.83% of the company’s stock.

Embecta Price Performance

Shares of EMBC opened at $12.52 on Thursday. Embecta Corp. has a 1 year low of $9.93 and a 1 year high of $21.48. The stock has a 50 day simple moving average of $14.90 and a two-hundred day simple moving average of $16.20. The firm has a market cap of $727.84 million, a P/E ratio of 12.52, a P/E/G ratio of 0.78 and a beta of 1.27.

Embecta (NASDAQ:EMBC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $0.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.20. Embecta had a net margin of 5.25% and a negative return on equity of 19.22%. On average, equities analysts anticipate that Embecta Corp. will post 2.85 earnings per share for the current year.

Embecta Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a dividend of $0.15 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 4.79%. Embecta’s dividend payout ratio (DPR) is currently 60.00%.

Insider Transactions at Embecta

In other Embecta news, Director Milton Mayo Morris sold 3,100 shares of Embecta stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $16.38, for a total value of $50,778.00. Following the transaction, the director now directly owns 36,133 shares of the company’s stock, valued at $591,858.54. The trade was a 7.90 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.42% of the company’s stock.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.